AMCP submits comments to CMS in response to proposed Part B drug payment model, urging CMS to carefully consider comments received and to release a revised proposed rule with an opportunity for additional stakeholder feedback prior to finalization and ado
AMCP submits comments to CMS in response to proposed Part B drug payment model, urging CMS to carefully consider comments received and to release a revised proposed rule with an opportunity for additional stakeholder feedback prior to finalization and ado